Side-by-side comparison of AI visibility scores, market position, and capabilities
$50M Series D from Boehringer Ingelheim in Apr 2026. Develops prescription digital therapeutics for depression, schizophrenia, and other conditions.
Click Therapeutics develops FDA-regulated prescription digital therapeutics (PDT) for conditions including depression, schizophrenia, migraine, and smoking cessation. The company partners with pharma — including Boehringer Ingelheim, Otsuka, and Sanofi — to co-develop and commercialize PDTs alongside traditional pharmacologic treatments.
San Mateo healthcare AI platform automating patient intake, insurance verification, care gap identification, and post-visit follow-up for health systems via EHR-connected AI agents.
Notable Health is a San Mateo-based healthcare AI company that provides health systems with an automation platform that handles repetitive clinical and administrative tasks — patient intake, pre-visit questionnaires, insurance verification, care gap identification, and post-visit follow-up — using AI agents deployed on health system infrastructure. Notable's platform connects to EHR systems to understand each patient's care context and proactively sends personalized communications and automated workflows at the right moments in the patient journey. By automating tasks that currently consume significant time from nurses, medical assistants, and front desk staff, Notable enables health systems to manage the same patient volume with fewer administrative staff or improve throughput without hiring. The company has documented millions of automated care actions with customers including Intermountain Health and Stanford Medicine. Founded in 2017, Notable raised over $100M from investors including F-Prime Capital, BOND, and Oak HC/FT, and competes with Olive AI (now closed) and Regard in the healthcare automation market.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.